Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
TYME and The Joseph Ahmed Foundation Announce First Patient Dosed in Phase II (HopES) Trial Evaluating the Potential Benefits of Oral SM-88 for Patients...
Firstwordpharma News
-
January 16, 2020
Phase II
Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study of Investigational Agent Alvocidib in Patients with Relapsed or Refractory Acute Myeloid...
Phase II
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
Phase II
Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone Disease
Phase II
Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study
Phase II
PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel for...
Firstwordpharma News
-
January 8, 2020
0
Phase II
OrphoMed Initiates U.S. Phase 2 Adaptive Design Study of ORP-101 for...
Firstwordpharma News
-
January 7, 2020
0
Phase II
Cytokinetics Announces Start of Redwood-HCM, a Phase 2 Clinical Trial of...
Biospace News
-
January 6, 2020
0
Phase II
Spectrum’s poziotinib misses main goal in Phase II lung cancer study;...
Firstwordpharma News
-
December 27, 2019
0
Phase II
Spectrum’s poziotinib misses main goal in Phase II lung cancer study;...
Firstwordpharma News
-
December 27, 2019
0
1
2
3
...
25
Page 1 of 25
- Advertisement -
MOST POPULAR
Kaiku Health and Amgen roll out digital patient support for Multiple...
February 28, 2019
Beactica Secures Another Round of Financing as Novel Glioblastoma Treatment Advances...
June 4, 2019
Following Two Novartis Deals, IFM Therapeutics Launches Third Subsidiary and Incubator
December 2, 2019
Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3
June 21, 2019
Load more
HOT NEWS
Others
Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital...
Commercial
Valeo Pharma Inc. Reports 2019 First Quarter Results
Deals
IDEAYA Licenses Phase 1 Compound LXS196 For The Treatment Of Cancers...
Others
China Has Big Presence in Top 10 Biotech IPOs this Year
